Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Australia shares eye record monthly gain on vaccine cheer, rebound hopes

Published 30/11/2020, 11:15 am
© Reuters.
AXJO
-
AXMM
-
AXEJ
-
AXFJ
-
TWE
-
NZ50
-

* Index set to add about 12% in November

* Financials poised to post record monthly gain of over 17%

* Australia's Q3 GDP +2.5% QOQ - Reuters poll

* NZ bourse set for second consecutive monthly gain

Nov 30 (Reuters) - Australian shares opened higher on Monday, and were on track to post their biggest monthly gain, as optimism surrounding COVID-19 vaccine candidates and hopes of an economic recovery in the coming year boosted risk appetite.

The S&P/ASX 200 index .AXJO was up 0.5% at 6,632.90 by 2330 GMT. It was on track to add nearly 12% in November, its biggest monthly gain on record.

Optimism around multiple potential effective coronavirus treatments buoyed global stock markets this month, with hopes of a swift economic recovery in 2021 further bolstering the gains.

Investors will be eyeing third-quarter gross domestic product data due on Wednesday that is expected to show a rebound in the economy - a likely 2.5% growth in September quarter from a 7% contraction in the June quarter, according to a Reuters poll. another solid gain likely in Q4 and the growth outlook looking positive for 2021, GDP could be back to its pre-pandemic level sometime in 2021," analysts at ANZ said in a note.

Heavyweight financials sub-index .AXFJ gained 0.5% on the back of blue-chip banking stocks, with the sector on track to post a record monthly gain of more than 17%.

Miners .AXMM were set to post their best month since May, while energy companies .AXEJ were poised to add more than 30% in November, their record monthly gain.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Meanwhile, an 11.8% fall in Treasury Wine Estates TWE.AX weighed a little on the index after the winemaker said it would redirect some wine intended for China and cut costs after Beijing imposed anti-dumping tariffs on Australian wine. New Zealand, the benchmark S&P/NZX 50 index .NZ50 rose 0.5% to 12,703.12, on track to add more than 5% in November, likely its second consecutive monthly gain.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.